These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7518276)

  • 1. Exogenous zinc ion is required for inhibitory activity of botulinum neurotoxin C1 against norepinephrine release and its endopeptidase activity toward substance P.
    Yokosawa N; Suga K; Kimura K; Tsuzuki K; Fujii N; Oguma K; Yokosawa H
    Biochem Mol Biol Int; 1994 Mar; 32(3):455-63. PubMed ID: 7518276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
    Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
    Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activity of botulinum neurotoxin type E and its light chain: cleavage of actin.
    DasGupta BR; Tepp W
    Biochem Biophys Res Commun; 1993 Jan; 190(2):470-4. PubMed ID: 8427588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
    Shone CC; Roberts AK
    Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of zinc in the structure and toxic activity of botulinum neurotoxin.
    Fu FN; Lomneth RB; Cai S; Singh BR
    Biochemistry; 1998 Apr; 37(15):5267-78. PubMed ID: 9548758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active.
    Ahmed SA; McPhie P; Smith LA
    Biochemistry; 2003 Nov; 42(43):12539-49. PubMed ID: 14580200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin.
    Schiavo G; Shone CC; Rossetto O; Alexander FC; Montecucco C
    J Biol Chem; 1993 Jun; 268(16):11516-9. PubMed ID: 8505288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and biological activity of botulinum neurotoxin.
    DasGupta BR
    J Physiol (Paris); 1990; 84(3):220-8. PubMed ID: 2074545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
    Fernández-Salas E; Ho H; Garay P; Steward LE; Aoki KR
    Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
    Cornille F; Roques BP
    J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of norepinephrine secretion from digitonin permeabilized PC12 cells by botulinum type D toxin.
    Yokosawa N; Fujii N; Tsuzuki K; Kimura K; Syuto B; Moriishi K; Oguma K
    Toxicon; 1992 Dec; 30(12):1555-62. PubMed ID: 1488764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin light chain inhibits norepinephrine secretion in PC12 cells at an intracellular membranous or cytoskeletal site.
    Lomneth R; Martin TF; DasGupta BR
    J Neurochem; 1991 Oct; 57(4):1413-21. PubMed ID: 1895112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin.
    Bartels F; Bergel H; Bigalke H; Frevert J; Halpern J; Middlebrook J
    J Biol Chem; 1994 Mar; 269(11):8122-7. PubMed ID: 8132537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent release of norepinephrine from permeabilized PC12 cells is inhibited by approximately 48 and approximately 112 kDa fragments of botulinum neurotoxin type E.
    Lomneth R; Gimenez J; Martin TF; DasGupta BR
    Neuropharmacology; 1993 Mar; 32(3):285-9. PubMed ID: 8474625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.
    Purcell AL; Hoard-Fruchey HM
    Anal Biochem; 2007 Jul; 366(2):207-17. PubMed ID: 17548044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells.
    Giménez J; Lomneth R; DasGupta BR
    Toxicon; 1994 Sep; 32(9):1137-46. PubMed ID: 7801349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase.
    Kukreja RV; Sharma S; Cai S; Singh BR
    Biochim Biophys Acta; 2007 Feb; 1774(2):213-22. PubMed ID: 17189717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2(+)-dependent noradrenaline release from permeabilised PC12 cells is blocked by botulinum neurotoxin A or its light chain.
    McInnes C; Dolly JO
    FEBS Lett; 1990 Feb; 261(2):323-6. PubMed ID: 2311761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.